Dr. Vincent Granowicz, DO

NPI: 1528057270
Total Payments
$7,042
2021 Payments
$250.01
Companies
27
Transactions
147
Medicare Patients
465
Medicare Billing
$34,539

Payment Breakdown by Category

Food & Beverage$6,827 (96.9%)
Research$150.00 (2.1%)
Education$65.00 (0.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,827 144 96.9%
Unspecified $150.00 1 2.1%
Education $65.00 2 0.9%

Payments by Type

General
$6,892
146 transactions
Research
$150.00
1 transactions

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $2,194 60 $0 (2020)
Teva Pharmaceuticals USA, Inc. $666.56 3 $0 (2017)
Boehringer Ingelheim Pharmaceuticals, Inc. $585.86 5 $0 (2019)
Merck Sharp & Dohme Corporation $487.01 15 $0 (2019)
Novo Nordisk Inc $482.11 13 $0 (2021)
Lilly USA, LLC $444.25 7 $0 (2020)
Janssen Pharmaceuticals, Inc $258.79 3 $0 (2018)
Amgen Inc. $216.67 2 $0 (2018)
SANOFI-AVENTIS U.S. LLC $202.23 3 $0 (2018)
Indivior Inc. $150.00 1 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2021 $250.01 9 GlaxoSmithKline, LLC. ($139.57)
2020 $729.65 23 AstraZeneca Pharmaceuticals LP ($322.79)
2019 $1,522 30 AstraZeneca Pharmaceuticals LP ($916.16)
2018 $1,695 37 AstraZeneca Pharmaceuticals LP ($639.82)
2017 $2,846 48 Teva Pharmaceuticals USA, Inc. ($666.56)

All Payment Transactions

147 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
09/02/2021 Biohaven Pharmaceuticals, Inc. NURTEC ODT (Drug) Food and Beverage In-kind items and services $11.62 General
Category: PRIMARY CARE
08/28/2021 Novo Nordisk Inc Food and Beverage In-kind items and services $15.09 General
07/17/2021 Biohaven Pharmaceuticals, Inc. NURTEC ODT (Drug) Food and Beverage In-kind items and services $15.14 General
Category: PRIMARY CARE
05/26/2021 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $122.03 General
Category: RESPIRATORY
05/18/2021 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $17.54 General
Category: RESPIRATORY
04/28/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $26.83 General
Category: NEUROSCIENCE
03/13/2021 Novo Nordisk Inc Food and Beverage In-kind items and services $13.35 General
02/11/2021 Biohaven Pharmaceuticals, Inc. NURTEC ODT (Drug) Food and Beverage In-kind items and services $12.23 General
Category: PRIMARY CARE
01/28/2021 Novo Nordisk Inc Food and Beverage In-kind items and services $16.18 General
12/23/2020 VIVUS, Inc. QSYMIA (Drug) Food and Beverage In-kind items and services $15.57 General
Category: ENDOCRINOLOGY
12/16/2020 Allergan, Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $11.73 General
Category: NEUROSCIENCE
12/07/2020 Biohaven Pharmaceuticals, Inc. NURTEC ODT (Drug) Food and Beverage In-kind items and services $12.00 General
Category: PRIMARY CARE
11/24/2020 Allergan, Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $19.90 General
Category: NEUROSCIENCE
10/31/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $18.30 General
Category: Cardiovascular and Metabolism
10/28/2020 VIVUS, Inc. QSYMIA (Drug) Food and Beverage In-kind items and services $13.98 General
Category: ENDOCRINOLOGY
10/23/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $11.11 General
Category: Diabetes
10/14/2020 Allergan, Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $14.66 General
Category: NEUROSCIENCE
10/09/2020 Eisai Inc. Dayvigo (Drug) Food and Beverage Cash or cash equivalent $18.54 General
Category: Neurology
10/08/2020 Allergan, Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.36 General
Category: NEUROSCIENCE
09/30/2020 Allergan, Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $27.62 General
Category: NEUROSCIENCE
09/26/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $13.70 General
Category: Cardiovascular and Metabolism
09/24/2020 VIVUS, Inc. QSYMIA (Drug) Food and Beverage In-kind items and services $18.78 General
Category: ENDOCRINOLOGY
08/28/2020 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $25.00 General
Category: Diabetes
08/26/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $16.20 General
Category: Diabetes
08/19/2020 Lilly USA, LLC BASAGLAR (Drug), TRULICITY, JARDIANCE Food and Beverage In-kind items and services $20.94 General
Category: Diabetes

Research Studies & Clinical Trials

Study Name Company Amount Records
Quantitative Testing of Prescriber/Pharmacist Knowledge, Attitudes and Behavior about SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) or the Authorized Generic of SUBOXONE Sublingual Film (CIII) Safety and Use Information Indivior Inc. $150.00 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 5 150 298 $28,332 $17,038
2020 10 315 509 $36,711 $17,501
Total Patients
465
Total Services
807
Medicare Billing
$34,539
Procedure Codes
15

All Medicare Procedures & Services

15 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 70 179 $25,955 $15,749 60.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 12 13 $1,365 $756.10 55.4%
83036 Hemoglobin a1c level Office 2021 21 30 $600.00 $291.30 48.6%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2021 23 49 $196.00 $160.72 82.0%
36415 Insertion of needle into vein for collection of blood sample Office 2021 24 27 $216.00 $81.00 37.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 73 166 $23,860 $12,467 52.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 41 53 $5,370 $2,035 37.9%
90688 Vaccine for influenza for administration into muscle, 0.5 ml dosage Office 2020 29 29 $1,015 $554.24 54.6%
82274 Stool analysis for blood Office 2020 32 34 $850.00 $538.08 63.3%
76775 Ultrasound behind abdominal cavity, limited Office 2020 15 15 $2,700 $458.19 17.0%
83036 Hemoglobin a1c level Office 2020 24 47 $940.00 $444.19 47.3%
G0008 Administration of influenza virus vaccine Office 2020 21 21 $525.00 $358.13 68.2%
97032 Application of electrical stimulation to 1 or more areas, each 15 minutes Office 2020 15 27 $783.00 $284.67 36.4%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2020 25 67 $268.00 $215.15 80.3%
36415 Insertion of needle into vein for collection of blood sample Office 2020 40 50 $400.00 $146.13 36.5%

About Dr. Vincent Granowicz, DO

Dr. Vincent Granowicz, DO is a Family Medicine healthcare provider based in Royal Oak, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528057270.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vincent Granowicz, DO has received a total of $7,042 in payments from pharmaceutical and medical device companies, with $250.01 received in 2021. These payments were reported across 147 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($6,827).

As a Medicare-enrolled provider, Granowicz has provided services to 465 Medicare beneficiaries, totaling 807 services with total Medicare billing of $34,539. Data is available for 2 years (2020–2021), covering 15 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Royal Oak, MI
  • Active Since 10/17/2005
  • Last Updated 10/24/2013
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1528057270

Products in Payments

  • FARXIGA (Drug) $2,053
  • COPAXONE (Drug) $666.56
  • JARDIANCE (Drug) $462.93
  • BELSOMRA (Drug) $334.22
  • INVOKANA (Drug) $233.60
  • Tresiba (Drug) $208.45
  • TRULICITY (Drug) $193.22
  • BUPRENORPHINE AND NALOXONE (Drug) $150.00
  • TRELEGY ELLIPTA (Drug) $139.57
  • VYVANSE (Drug) $137.78
  • BASAGLAR (Drug) $135.38
  • BYDUREON (Drug) $124.86
  • BELBUCA (Drug) $123.00
  • Repatha (Biological) $122.70
  • Xultophy 100/3.6 (Drug) $121.84
  • TOUJEO (Drug) $110.17
  • PRALUENT ALIROCUMAB INJECTION (Biological) $107.25
  • ImmunoCAP (Device) $98.52
  • ENTRESTO (Drug) $97.67
  • PRESTIGE (Device) $96.55

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Royal Oak